Summary
The product Testosterone Cypionate, manufactured by Pharmaqo, underwent independent testing to verify its authenticity and potency. The sample, with an unknown batch number, was submitted by the Manufacturer Pharmaqo Labs TESTSK-C and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Testosterone Cypionate, with a concentration of 226.89 mg/ml, exceeding the standard concentration of 200 mg/ml by 13.45%.
The testing process began on 7 June 2023, with the sample received on 30 June 2023, and analysis completed on the same day. While the results confirm accurate dosing, scrutiny of Mmanufacturer-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Testosterone Cypionate
- Active Ingredient: Testosterone Cypionate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #30656
- Testing Ordered: 7 June 2023
- Sample Received: 30 June 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 200 mg/ml (standard concentration)
- Measured Concentration: 226.89 mg/ml
- Accuracy: 113.45% (13.45% above the standard concentration)
- Variance: 13.45
Verification Details
- Verification URL: https://janoshik.com/tests/30656_6I7PBPD4GM5M
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the Manufacturer Pharmaqo Labs TESTSK-C. Manufacturer-submitted samples may not fully represent the consistency of products available in the broader market. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Testosterone Cypionate is significantly overdosed, with a measured concentration of 226.89 mg/ml. This result reflects strong quality control for this sample but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
